Agaricus Blazei (ABM).

The active fraction of Agaricus blazei is a beta-1,3/1,6 glucan that binds dectin-1 and complement receptor 3 on innate immune cells. Added glucan raises the ligand load at those same receptors.

Vitamin D receptor signalling shapes how innate immune cells respond once a glucan engages dectin-1, including antimicrobial peptide expression. Adequate vitamin D status is the background condition for that response.

Zinc is required for normal development and signalling of the immune cells that respond to mushroom glucans. Without adequate zinc the downstream response to the glucan signal is blunted.

Agaricus blazei takes up minerals from its substrate and converts inorganic selenium into organic selenium species, so selenium-enriched cultivation changes what the finished powder delivers. The same accumulation behaviour applies to unwanted elements, which is why the cited work looked at cadmium at the same time. This is agronomy affecting the raw material, not a co-ingestion effect in people.

Both mushrooms supply beta-(1,3)(1,6)-D-glucans, which are recognised by dectin-1 and complement receptor 3 on innate immune cells. Stacking two glucan sources raises total glucan intake and is the usual reason blends exist. No combination trial is cited, so the pairing is mechanistic and the immune readouts involved are markers rather than outcomes.

Turkey tail's protein-bound polysaccharides and Agaricus blazei's glucans are read by the same class of pattern-recognition receptors. Blend products rely on that overlap for total glucan load. What the combination does in a person has not been tested here, and immune-marker movement is not a health outcome.

Maitake beta-glucan and Agaricus blazei polysaccharides act on the same dectin-1 route, so the two are commonly combined rather than compared. Extraction method changes how much solubilised glucan is delivered, whichever species is used. Mechanistic pairing, untested as a unit.

Cordyceps brings nucleosides such as cordycepin and adenosine alongside its own polysaccharides, which is a different chemistry from Agaricus blazei's glucans. They appear together in blends for breadth, not because a joint effect has been shown. Early is the honest band.

Lion's mane is used for its hericenones and erinacines rather than its glucan content, so pairing it with Agaricus blazei covers two different formulation intentions. No combination data is cited. The row exists to record the practice.

Human digestive enzymes cannot break beta-(1,3)(1,6) glucan linkages, so a large share of an oral dose reaches the colon as fermentable substrate alongside a fructan like inulin. Animal work on Agaricus blazei polysaccharide reports shifts in gut barrier and microbial measures on that basis. Combining two fermentable substrates also raises the chance of gas and bloating in sensitive people.

Undigested mushroom glucans are a substrate that resident and supplemented bacteria can ferment, which is the standard rationale for pairing a polysaccharide with live strains. Evidence for Agaricus blazei specifically sits in animal microbiota work, not human co-supplementation trials. Framed as substrate chemistry, not a demonstrated joint benefit.

Ascorbate is added to nearly every immune-support formula for its own established role in normal immune function, and it does not interact with glucan receptor binding. The pairing is convention. No combination study is cited.

Yeast-derived beta-(1,3)(1,6)-D-glucan is the most characterised glucan for dectin-1 binding, and the fungal glucans in Agaricus blazei work through the same recognition. Adding both raises total glucan without changing the mechanism. Solubility and branching differ between sources, and neither delivers a measured clinical outcome on this evidence.